Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 21 of 21 entries
View as:

Efficacy, Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ZYIL1 in Patients With Amyotrophic Lateral Sclerosis

Phase: N/A Priority: Normal
NCT ID: NCT05981040 Org: User:
Start: 11/09/23 End: 06/26/24 Due: 06/26/25

A Clinical Study to Evaluate Safety, Tolerability and Pharmacokinetics of Oral ZYGK1 in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01472809 Org: User:
Start: 12/31/11 End: - Due: -

A Clinical Study to Evaluate the Safety,Tolerability and PK of ZYT1, Following Oral Administration in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01543269 Org: User:
Start: 02/28/10 End: 07/31/12 Due: 07/31/13

A Study Of Zy-19489 Administered Via Oral Route To Investigate The Safety, Tolerability And Pharmacokinetics In Healthy Adult Human Subjects

Phase: N/A Priority: Normal
NCT ID: NCT05206201 Org: User:
Start: 08/25/21 End: 01/21/22 Due: 01/21/23

A Clinical Trial to Evaluate the Safety and Efficacy of ZYH7 Compared to Fenofibrate in Patients With Dyslipidemia

Phase: N/A Priority: Normal
NCT ID: NCT01539616 Org: User:
Start: 11/30/11 End: 08/31/12 Due: 08/31/13

A Clinical Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ZYD1, Following Subcutaneous Administration in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01972893 Org: User:
Start: 02/28/11 End: 06/30/12 Due: 06/30/13

A Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ZYIL1 in Subjects With Cryopyrin Associated Periodic Syndromes (CAPS)

Phase: N/A Priority: Normal
NCT ID: NCT05186051 Org: User:
Start: 06/01/22 End: 07/02/22 Due: 07/02/23

Pegylated Interferon - α2b With SARSCoV- 2 (COVID-19)

Phase: N/A Priority: Normal
NCT ID: NCT04480138 Org: User:
Start: 08/11/20 End: 06/21/21 Due: 06/21/22

Desidustat in the Treatment of Chemotherapy Induced Anemia

Phase: N/A Priority: Normal
NCT ID: NCT04667533 Org: User:
Start: 11/11/20 End: 05/10/22 Due: 05/10/23

Desidustat in the Treatment of Anemia in CKD

Phase: N/A Priority: Normal
NCT ID: NCT04012957 Org: User:
Start: 07/20/19 End: 08/25/21 Due: 08/25/22

To Compare the Efficacy and Safety of Clindamycin Phosphate 1.2% / Benzoyl Peroxide 5% Gel of CHL Versus DUAC® Gel

Phase: N/A Priority: Normal
NCT ID: NCT02005666 Org: User:
Start: 11/30/13 End: 09/28/16 Due: 09/28/17

Desidustat in the Management of COVID-19 Patients

Phase: N/A Priority: Normal
NCT ID: NCT04463602 Org: User:
Start: 07/25/20 End: 03/31/21 Due: 03/31/22

A Study to Evaluate the Safety and Effectiveness of Saroglitazar 4 mg in Patients With NAFLD With Comorbidities

Phase: N/A Priority: Normal
NCT ID: NCT05872269 Org: User:
Start: 07/20/23 End: 06/10/25 Due: 06/10/26

A Study to Evaluate Safety, Efficacy, Pharmacokinetics, and Immunogenicity of Test Pertuzumab (ZRC-3277, Cadila Healthcare Ltd.,)

Phase: N/A Priority: Normal
NCT ID: NCT05283837 Org: User:
Start: 09/26/22 End: 09/06/23 Due: 09/06/24

A Clinical Study to Evaluate the Safety, Tolerability and Pharmacokinetics and Pharmacodynamics of ZYIL1 Following Oral Administration in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT04972188 Org: User:
Start: 07/12/21 End: 10/25/21 Due: 10/25/22

A Post Marketing Surveillance to Evaluate the Safety of Desidustat for the Treatment of Anemia in Subjects With Chronic Kidney Disease (CKD).(Real World Evidence Study)

Phase: N/A Priority: Normal
NCT ID: NCT05515367 Org: User:
Start: 04/20/23 End: 11/30/25 Due: 11/30/26

A Study to Determine Safety, Tolerability, and Pharmacokinetics of Different Orally Administered Regimens of the Combination ZY19489-Ferroquine in Adult Asymptomatic Plasmodium Falciparum Carriers

Phase: N/A Priority: Normal
NCT ID: NCT05911828 Org: User:
Start: 08/30/24 End: 05/30/25 Due: 05/30/26

Clinical Study to Evaluate the Safety, Tolerability and Pharmacokinetics and Pharmacodynamics of ZYIL1 Following Oral Administration in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT04731324 Org: User:
Start: 12/28/20 End: 06/12/21 Due: 06/12/22

Desidustat in the Treatment of Anemia in CKD on Dialysis Patients

Phase: N/A Priority: Normal
NCT ID: NCT04215120 Org: User:
Start: 01/04/20 End: 09/02/21 Due: 09/02/22

A Study to Evaluate the Efficacy and Safety of ZYIL1 Oral Capsules for the Treatment of Patients With Mild to Moderately Active Ulcerative Colitis Resistant or Intolerant to Oral Aminosalicylates

Phase: N/A Priority: Normal
NCT ID: NCT06398808 Org: User:
Start: 04/08/24 End: 11/28/24 Due: 11/28/25

Clinical Study to Evaluate the Safety, Tolerability and Pharmacokinetics (PKs) of ZYDPLA1 Following Oral Administration in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02620592 Org: User:
Start: 10/31/14 End: 10/31/15 Due: 10/31/16